Trials / Completed
CompletedNCT06245811
Inflammation Markers in Hyperemesis Gravidarum
Evaluation of the Relationship Between Hyperemesis Gravidarum (HEG) With Platelet Crit (PCT), Haemoglobin to Red Cell Distribution Width Ratio (HRR) and Neutrophil to Lymphocyte Ratio (NLR).
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 215 (actual)
- Sponsor
- Izzet Celegen · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
In this study, the relationship between the severity of hyperemesis gravidarum (HEG) disease and subclinical inflammatory factors such as Platelet Crit (PCT), Hemoglobin/red cell distribution width ratio (HRR), Neutrophil/lymphocyte ratio (NLR), was investigated.
Detailed description
A total of 215 pregnant women, 102 with hyperemesis gravidarum and 113 healthy pregnant women, were included in the study. HEG patients were divided into three groups according to the modified PUQE classification: mild (n=38), moderate (n=32) and severe (n=32). In our study, we proposed using a new prognostic marker for HEG patients. We think that our study will be a source for future studies on HEG.
Conditions
Timeline
- Start date
- 2022-01-20
- Primary completion
- 2022-03-20
- Completion
- 2022-06-20
- First posted
- 2024-02-07
- Last updated
- 2024-02-07
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06245811. Inclusion in this directory is not an endorsement.